Ethanol Extract of Liriope platyphylla Root Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice via Regulation of Lipogenesis and Lipid Uptake

Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice

(2021) Shan-Shan Lei et al.   Evidence-based Complementary and Alternative Medicine

Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans

(2021) Dong-Hyuk Jung et al.   Clinical Interventions in Aging

Complications, morbidity and mortality of nonalcoholic fatty liver disease

(2020) Alessandro Mantovani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Pluchea indica (L.) Less. Tea Ameliorates Hyperglycemia, Dyslipidemia, and Obesity in High Fat Diet-Fed Mice

(2020) Kittipot Sirichaiwetchakoon et al.   Evidence-based Complementary and Alternative Medicine

Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression protects against high fat diet-induced obesity and hepatic steatosis in mice

(2020) Zhi-Hong Luo et al.   CHINESE MEDICAL JOURNAL

A Combination of Apple Vinegar Drink with Bacillus coagulans Ameliorates High Fat Diet-Induced Body Weight Gain, Insulin Resistance and Hepatic Steatosis

(2020) Raquel Urtasun et al.   Nutrients

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

(2020) Daniel Q. Huang et al.   Nature Reviews Gastroenterology & Hepatology

Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice

(2019) Tomohiko Ohashi et al.   PLoS One

Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease

(2019) Jeongeun Mun et al.   Nutrients

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

(2018) David Højland Ipsen et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis

(2018) Bei Li et al.   Canadian Journal of Gastroenterology and Hepatology

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Ishige okamurae Extract Suppresses Obesity and Hepatic Steatosis in High Fat Diet-Induced Obese Mice

(2018) Young-Jin Seo et al.   Nutrients

Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones

(2017) Caroline E Geisler et al.   JOURNAL OF ENDOCRINOLOGY

Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats

(2016) Jin-Hang Gao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Signal transducer and activator of transcription 5 plays a crucial role in hepatic lipid metabolism through regulation of CD36 expression

(2016) Atsushi Hosui et al.   HEPATOLOGY RESEARCH

Epidemiology and natural history of non-alcoholic fatty liver disease

(2016) Yousef Fazel et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease

(2016) Fareeba Sheedfar et al.   Aging-US

Natural Products on Nonalcoholic Fatty Liver Disease

(2015) Jiao-Ya Xu et al.   CURRENT DRUG TARGETS

IL-25 or IL-17E Protects against High-Fat Diet–Induced Hepatic Steatosis in Mice Dependent upon IL-13 Activation of STAT6

(2015) An-Jiang Wang et al.   JOURNAL OF IMMUNOLOGY

Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD

(2015) Michael Allison et al.   SEMINARS IN LIVER DISEASE

Gallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice

(2014) Jung Chao et al.   PLoS One

Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease

(2013) Jennifer E. Lambert et al.   GASTROENTEROLOGY

SLC27 fatty acid transport proteins

(2013) Courtney M. Anderson et al.   MOLECULAR ASPECTS OF MEDICINE

Extracts of Pomelo Peels Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice through Activating the PPARα and GLUT4 Pathway

(2013) Xiaobo Ding et al.   PLoS One

Polyphenol-Rich Fraction of Brown AlgaEcklonia cavaCollected from Gijang, Korea, Reduces Obesity and Glucose Levels in High-Fat Diet-Induced Obese Mice

(2012) Eun Young Park et al.   Evidence-based Complementary and Alternative Medicine

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity

(2012) Luis A. Videla et al.   PPAR Research

Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis

(2011) Claire Z Larter et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis

(2010) Safiyeh Aghazadeh et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling

(2010) Xiao-Qian Hu et al.   Lipids in Health and Disease

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid -Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

(2010) James P. Hardwick et al.   PPAR Research

Review: Treatment options for nonalcoholic fatty liver disease

(2010) Brian Lam et al.   Therapeutic Advances in Gastroenterology

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

(2008) Kristiaan Wouters et al.   HEPATOLOGY

The Korean traditional medicine Gyeongshingangjeehwan inhibits obesity through the regulation of leptin and PPARα action in OLETF rats

(2008) Sunhyo Jeong et al.   JOURNAL OF ETHNOPHARMACOLOGY